
Are we measuring progress in AI-driven drug discovery the right way? Rafael Rosengarten explores this question with Andrii Buvailo , co-founder of BioPharmaTrend and one of the industry’s most perceptive analysts of AI...


science
Hosted by Genialis · science · EN
Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
48%
Guest openness
Selective
Sign up to generate a grounded pitch for Talking Precision Medicine.
Signup to Generate a PitchWelcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine.
Talking Precision Medicine is hosted by Genialis. The show has published 62 episodes to date.
Recent episodes include "Andrii Buvailo | The Kodak moment for drug discovery: AI, adaptation, and what stays human | TPM podcast #61" (17 September 2026, 52 minutes), "Tim Wahlberg | What would you (and your AI) do with the world’s largest curated chemistry data catalog? | TPM podcast #60" (25 August 2026, 44 minutes), and "Jacob Hooker | From motifs to medicines: Harnessing nature’s pharmacopeia for novel CNS therapies | TPM podcast #59" (21 July 2026, 50 minutes).
Talking Precision Medicine publishes roughly monthly, with episodes averaging 45 minutes across 62 episodes.
Booking probability for Talking Precision Medicine is 48%, and the host is rated Selective on guests. Talking Precision Medicine requires a Pod Score of 80 or higher. Talking Precision Medicine's contact route on record: verified email.
The strongest fits for Talking Precision Medicine are Scientific Research & Development and Pharmaceuticals. Talking Precision Medicine has a science audience.
Genialis hosts Talking Precision Medicine, a science podcast with 62 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

Are we measuring progress in AI-driven drug discovery the right way? Rafael Rosengarten explores this question with Andrii Buvailo , co-founder of BioPharmaTrend and one of the industry’s most perceptive analysts of AI...

Artificial intelligence may be transforming drug discovery, but AI is only as powerful as the data it learns from. Behind many of today's scientific breakthroughs sits an invisible layer of expertly curated, harmonized...

Mental health remains one of medicine's greatest unmet needs. In this episode, Jacob Hooker explains how Sensorium Therapeutics is searching for new psychiatric medicines by combining traditional plant knowledge with...

Episode #6
In episode 58, Rafael sits down with James Zanewicz , CEO of Connect, to discuss the art and science of building innovation ecosystems. From Connect's origins as the world's first accelerator to the future of AI-powered...

In this episode, Rafael Rosengarten sits down with Lisa Gurry , Chief Business Officer at GeneDx, to discuss the transformative role of genomic testing in rare disease diagnosis, therapeutic discovery, and precision...

In this episode, Rafael Rosengarten sits down with Dr. Kamal Jethwani , VP of Digital Ventures at Moffitt Cancer Center, CEO of AccelerOnc Studio, and consulting CEO of Decimal Health. With over two decades in digital...

Precision oncology promises more data, more insight, and better decisions, yet in practice it often brings more complexity. In a new episode Rafael Rosengarten is joined by Dr. Shakti Ramkissoon , VP of Oncology at...

In this episode, Rafael Rosengarten speaks with Dr. Sean Khozin , CEO of the CEO Roundtable on Cancer. Sean shares how pre-competitive collaboration across industry, academia, and regulators is helping address some of...

In this episode, I’m joined by Colette Delawalla , founder and CEO of Stand Up For Science. What began as frustration over a federal “banned words” list evolved into a national mobilization effort to defend scientific...

In this episode, I’m joined by my longtime friend Ian Simon , Head of Biotechnology at Aspis Intelligence. Ian’s path runs from grad school vaccine research at Yale to senior roles at the White House, HHS, NIH, the...

In this episode Rafael sits down with Michelle Chen , President and CEO of Form Bio, a techbio company using AI to advance genome engineering and the development of genetic medicines. Michelle shares her zigzag journey...

Today I’m joined by Mike Rossi , Vice President of Translational Science and Multi-modal Real-World Evidence Solutions at ConcertAI. Mike has built a career at the intersection of genomics, data science, and oncology...

Joining us on this episode is Mida Pezeshkian, an old colleague and friend. Mida’s career has spanned from the depths of stem cell science as a student to her current focus on product management in healthcare. We talk...

Today on the show, I’m joined by Michael Montalto , vice president of precision medicine at Amgen. Amgen is widely recognized as one of the most successful pharmaceutical companies in translating research and...

Joining us on this episode is Tom Neyarapally , co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is an AI-native biotech pioneering the use of...

Stéphane Budel , founding partner at DeciBio, joins the Talking Precision Medicine Podcast to explore the future of the field. He unpacks how liquid biopsy, multi-omics, and AI are opening new doors for personalized...

Today’s guests are Anna Berkenblit , Chief Scientific and Medical Officer at the Pancreatic Cancer Action Network, and Sudheer Doss , Chief Business Officer at PanCAN. The Pancreatic Cancer Action Network is the leading...

Episode #3
Today’s guest is Najat Khan , Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals. Recursion is widely recognized as one of the most visible—and so far, most successful—companies to emerge from...

Episode #2
What a pleasure to welcome today’s guest, Ryan Fukushima , chief operating officer of TempusAI. Not only has Ryan helped build Tempus brick by brick from the earliest days, he is also CEO of Pathos AI, a biotech company...

Today my guest is Joydeep Goswami , newly appointed President and CEO of the storied biotechnology company LGC. Joydeep is also a strategy advisor to Genialis. Join us as we discuss his remarkable career and lessons...
Recent guests on Talking Precision Medicine. Study who booked and why before you pitch.
PitchCentric classifies Talking Precision Medicine under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.

Precision Medicine Podcast

AI Explained: Healthcare and Life Sciences

Agilent “Dialogues in CDx” Podcast Series

Practical AI in Healthcare

The Best AI Show on Pharma

Precision Health and PGx Podcast
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ